Using an inexpensive 3-D printer, biomedical engineers have developed a custom-fitted, implantable device with embedded sensors that could transform treatment and prediction of cardiac disorders.
Igor Efimov, PhD, at the School of Engineering & Applied Science at Washington University in St. Louis and an international team of biomedical engineers and materials scientists have created a 3-D elastic membrane made of a soft, flexible, silicon material that is precisely shaped to match the heart’s epicardium, or the outer layer of the wall of the heart. Current technology is two-dimensional and cannot cover the full surface of the epicardium or maintain reliable contact for continual use without sutures or adhesives.
The team can then print tiny sensors onto the membrane that can precisely measure temperature, mechanical strain and pH, among other markers, or deliver a pulse of electricity in cases of arrhythmia. Those sensors could assist physicians with determining the health of the heart, deliver treatment or predict an impending heart attack before a patient exhibits any physical signs.
“Each heart is a different shape, and current devices are one-size-fits-all and don’t at all conform to the geometry of a patient’s heart,” says Efimov, the Lucy & Stanley Lopata Distinguished Professor of Biomedical Engineering. “With this application, we image the patient’s heart through MRI or CT scan, then computationally extract the image to build a 3-D model that we can print on a 3-D printer. We then mold the shape of the membrane that will constitute the base of the device deployed on the surface of the heart.”
Ultimately, the membrane could be used to treat diseases of the ventricles in the lower chambers of the heart or could be inserted inside the heart to treat a variety of disorders, including atrial fibrillation, which affects 3 million to 5 million patients in the United States.
“Currently, medical devices to treat heart rhythm diseases are essentially based on two electrodes inserted through the veins and deployed inside the chambers,” says Efimov, also a professor of radiology and of cell biology and physiology at the School of Medicine. “Contact with the tissue is only at one or two points, and it is at a very low resolution. What we want to create is an approach that will allow you to have numerous points of contact and to correct the problem with high-definition diagnostics and high-definition therapy.”
Co-leading the team with Efimov is John Rogers, PhD, the Swanlund Chair and professor of materials science and engineering and director of the F. Seitz Materials Research Laboratory at the University of Illinois at Urbana-Champaign. Rogers, who developed the transfer printing technique, developed the sensors using semiconductor materials including silicon, gallium arsenide and gallium nitride, along with metals, metal oxides and polymers.
Recently, Google announced its scientists had developed a type of contact lens embedded with sensors that could monitor glucose levels in patients with diabetes. Efimov says the membrane his team has developed is a similar idea, though much more sophisticated.
“Because this is implantable, it will allow physicians to monitor vital functions in different organs and intervene when necessary to provide therapy,” he says. “In the case of heart rhythm disorders, it could be used to stimulate cardiac muscle or the brain, or in renal disorders, it would monitor ionic concentrations of calcium, potassium and sodium.”
The Latest on: Transformative device for heart treatment
via Google News
The Latest on: Transformative device for heart treatment
- Verve Therapeutics Presents New Data in Non-Human Primates Validating Gene Editing as a Treatment Approach for Coronary Heart Disease at the ISSCR 2020 Virtual Annual Meetingon June 27, 2020 at 2:45 pm
Verve Therapeutics, a next-generation cardiovascular company, today announced the presentation of new preclinical proof-of-concept data in non-human p ...
- Wound treatment device maker ACell files for a $86 million IPOon June 26, 2020 at 2:27 pm
A Cell, which makes medical devices for wounds and soft tissue surgical defects, filed on Friday with the SEC to raise up to $86 million in an initial public offering. The company ...
- Less invasive heart treatment now available to all Australians living with aortic stenosison June 26, 2020 at 3:22 am
All Australians living with symptoms of severe aortic stenosis no longer face open heart surgery as the only treatment option ... therapeutic goods as part of the MMDR (Medicine and Medical Devices ...
- New Late-Breaking Data Highlight Impact of Abbott's Minimally Invasive Structural Heart Therapieson June 25, 2020 at 7:00 am
PRNewswire/ -- Abbott (NYSE: ABT) today announced late-breaking data on a number of its life-changing products to treat people with structural heart ...
- preCARDIA, Inc. Receives FDA Breakthrough Device Designation for Novel, Catheter Based Heart Failure Treatmenton June 23, 2020 at 2:10 pm
CARDIA, Inc., has announced that the company's catheter based system for treating volume overload in patients with acutely decompensated heart failure (ADHF) has been designated for the Breakthrough ...
- InfoBionic Plays Crucial Role in Monitoring Pandemic Lockdown Heart Effectson June 15, 2020 at 5:03 pm
As cities emerge from the pandemic lockdown, leading ambulatory cardiac monitoring provider InfoBionic and other industry experts are asking how the shutdowns can potentially affect heart health. One ...
- Covid-19 pandemic forces hospitals to scale upon June 11, 2020 at 3:20 pm
In the past two months, several people took to social media to express their dismay at being unable to find hospital beds or proper treatment for ... like diabetes and heart disease.
- Medical Sector Reaps the Benefits of Innovative Wearable Deviceson June 4, 2020 at 6:00 am
For example, the digital health sector is going through a period of strong growth as the transition to remote services has been significantly accelerated. Digital health products and services vary, ...
- Global Structural Heart Disease Treatment Devices Market 2020-2024 | Increasing Structural Heart Diseases to Boost Growth | Technavioon June 2, 2020 at 11:49 pm
LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global structural heart disease treatment devices market size and it is poised to grow by USD 5.61 billion during 2020-2024, progressing ...
- Diabetes defeated by diet: How new fresh-food prescriptions are beating pricey drugson June 21, 2018 at 4:02 am
"In health care we spend an awful lot on drugs and devices ... Feinberg told CNBC. "The impact is that we really know long-term that we'll see a decrease in incidence of heart disease, the No ...
via Bing News